← Evidence map

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2019

A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib.

Gina M Castellano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31254668